L
Lutz Trojan
Researcher at University of Göttingen
Publications - 167
Citations - 4388
Lutz Trojan is an academic researcher from University of Göttingen. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 29, co-authored 142 publications receiving 3837 citations. Previous affiliations of Lutz Trojan include John Radcliffe Hospital & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Complications in percutaneous nephrolithotomy.
TL;DR: A step-by-step approach to percutaneous nephrolithotomy and its complications and management is focused on, with the most important consideration for achieving consistently successful outcomes in PNL with minimal major complications being the correct selection of patients.
Journal ArticleDOI
Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer
Alexander Hermani,Jochen Hess,Barbara De Servi,Senad Medunjanin,Rainer Grobholz,Lutz Trojan,Peter Angel,Doris Mayer +7 more
TL;DR: The data suggest that enhanced expression of S100A8,S100A9, and RAGE is an early event in prostate tumorigenesis and may contribute to development and progression or extension of prostate carcinomas, and S 100A9 in serum may serve as useful marker to discriminate between prostate cancer and BPH.
Journal ArticleDOI
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Hubert Kübler,Birgit Scheel,Ulrike Gnad-Vogt,Kurt Miller,Wolfgang Schultze-Seemann,Frank vom Dorp,Giorgio Parmiani,Christian Hampel,Steffen Wedel,Lutz Trojan,Dieter Jocham,Tobias Maurer,Gerd Rippin,Mariola Fotin-Mleczek,Florian Von Der MüLBE,Jochen Probst,Ingmar Hoerr,Karl-Josef Kallen,Thomas Lander,Arnulf Stenzl +19 more
TL;DR: The self-adjuvanted RNActive® vaccine CV9103 was well tolerated and immunogenic, and the technology is a versatile, fast and cost-effective platform allowing for creation of vaccines.
Journal ArticleDOI
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga‐PSMA‐positron emission tomography/computerized tomography
Sameh Hijazi,Birgit Meller,Conrad Leitsmann,Arne Strauss,Johannes Meller,Christian Ritter,Joachim Lotz,Hans-Ulrich Schildhaus,Lutz Trojan,C. O. Sahlmann +9 more
TL;DR: The first evaluation of pelvic extended lymph node dissection (pLND) in oligometastatic prostate cancer (PCa) detected by 68Ga‐PSMA PET/CT is reported.
Journal ArticleDOI
Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer
Yongde Liao,Rainer Grobholz,Ulrich Abel,Lutz Trojan,Maurice Stephan Michel,Peter Angel,Doris Mayer +6 more
TL;DR: Data show that AKT is upregulated in prostate cancer and that expression is correlated with tumor progression and showed a positive correlation with high preoperative serum levels of prostate specific antigen.